| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10000021 | ASAVVDGAFK | S | 2 | |
| 10000022 | LSEDYGVLK | S | 2 | 112 |
| 10006299 | ATAVVDGAFK | T | 2 | 18 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10000021 | MS | HTP | unambiguous | human | erythrocytes | diabetic/normal | None | 18984734 | ||
| 10000022 | MS | HTP | unambiguous | human | erythrocytes | diabetic/normal | None | 18984734 | ||
| 10006299 | MS | HTP | unambiguous | human | erythrocytes | None | 18984734 | The sequence was descriebd as 'ASAVVDGAFK' in the original paper |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10000021 | ASAVVDGAFK | S | 2 | MS | HTP | unambiguous | human | erythrocytes | 18984734 | ||
| 10000022 | LSEDYGVLK | S | 2 | 112 | MS | HTP | unambiguous | human | erythrocytes | 18984734 | |
| 10006299 | ATAVVDGAFK | T | 2 | 18 | MS | HTP | unambiguous | human | erythrocytes | 18984734 | The sequence was descriebd as 'ASAVVDGAFK' in the original paper |